Zusammenfassung
Das Kapitel bietet eine umfassende Darstellung der neoplastischen Erkrankungen der Harnblase und der ableitenden Harnwege. Auf der Basis der WHO-Klassifikation und ihrer Modifikationen wird zu den häufigen wie auch zu den seltenen Tumoren Stellung genommen und ihre prognostische Bedeutung herausgestellt. Die Morphologie der Tumoren wird durch generelle Informationen zur Epidemiologie und Genetik ergänzt. Hervorgehoben wird die Differentialdiagnose der Tumoren, insbesondere unter Anwendung immunhistochemischer Marker. Makroskopie und Histologie der Tumoren werden durch repräsentatives Bildmaterial verdeutlicht.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Akdaş A, Türkeri L (1991) The impact of squamous metaplasia in transitional cell carcinoma of the bladder. Int Urol Nephrol 23:333–336
Anagnostou E, Miliaras D, Panagiotakopoulos V (2011) Diagnosis of gastrointestinal stromal tumor (GIST) on transurethral resection of the prostate: a case report and review of the literature. Int J Surg Pathol 19:632–636
Agaimy A, Pelz AF, Corless CL, Wünsch PH, Heinrich MC, Hofstaedter F, Dietmaier W, Blanke CD, Wieacker P, Roessner A, Hartmann A, Schneider-Stock R (2007) Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. Oncol Rep 18:9–15
Ainsworth AM, Clark WH, Mastrangelo M, Conger KB (1976) Primary malignant melanoma of the urinary bladder. Cancer 37:1928–1936
Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB (2001) Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World Health Organization/International Society of Urologic Pathology. Mod Pathol 14:267–272
Al-Quran SZ, Olivares A, Lin P, Stephens TW, Medeiros LJ, Abruzzo LV (2006) Myeloid sarcoma of the urinary bladder and epididymis as a primary manifestation of acute myeloid leukemia with inv(16). Arch Pathol Lab Med 130:862–866
Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23:8812–8818
Amin MB, Ro JY, el-Sharkawy T, Lee KM, Troncoso P, Silva EG, Ordóñez NG, Ayala AG (1994) Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 18:1224–1232
Amin MB, Gómez JA, Young RH (1997) Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 21:1057–1068
Amin MB (2009) Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol 22(Suppl 2):96–118
Armstrong AB, Wang M, Eble JN, MacLennan GT, Montironi R, Tan PH, Lopez-Beltran A, Zhang S, Baldridge LA, Spartz H, Cheng L (2009) TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol 22:113–118
Baldwin L, Lee AH, Al-Talib RK, Theaker JM (2005) Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinoma. Histopathology 46:50–56
Baydar D, Amin MB, Epstein JI (2006) Osteoclast-rich undifferentiated carcinomas of the urinary tract. Mod Pathol 19:161–171
Beilan J, Lawton A, Hajdenberg J, Rosser CJ (2013) Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature. BMC Urol 13:22
Black PC, Brown GA, Dinney CP (2009) The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 27:3–7
Bohn OL, Pardo-Castillo E, Fuertes-Camilo M, Rios-Luna NP, Martinez A, Sanchez-Sosa S (2011) Urinary bladder paraganglioma in childhood: a case report and review of the literature. Pediatr Dev Pathol 14:327–332
Brandes D, Katz RS (1989) Nonepithelial tumors of the ureters and urinary bladder. In: Hill GS (Hrsg) Uropathology. Churchill Livingstone, New York, S 861–872
Braun S, Riemann K, Kupka S, Leistenschneider P, Sotlar K, Schmid H, Blin N (2005) Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas. Anticancer Res 25:2809–2814
Bullock PS, Thoni DE, Murphy WM (1987) The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract. Cancer 59:2086–2090
Burgués O, Ferrer J, Navarro S, Ramos D, Botella E, Llombart-Bosch A (1999) Hepatoid adenocarcinoma of the urinary bladder. An unusual neoplasm. Virchows Arch 435:71–75
Burton EM, Schellhammer PF, Weaver DL, Woolfitt RA (1986) Paraganglioma of urinary bladder in patient with neurofibromatosis. Urology 27:550–552
Charfi S, Ellouze S, Mnif H, Amouri A, Khabir A, Sellami-Boudawara T (2012) Plasmacytoid melanoma of the urinary bladder and lymph nodes with immunohistochemical expression of plasma cell markers revealing primary esophageal melanoma. Case Rep Pathol. 2012; 2012:916256. doi: 10.1155/2012/916256. Epub 20112 Oct 24
Chen YB, Epstein JI (2011) Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clinicopathologic study of 6 cases. Am J Surg Pathol 35:442–446
Cheng L, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE, Bostwick DG (1999) Survival of patients with carcinoma in situ of the urinary bladder. Cancer 85:2469–2474
Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Neumann RM, Nascimento AG, Zincke H, Bostwick DG (2000) Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer 88:844–852
Cheng L, Cheville JC, Sebo TJ, Eble JN, Bostwick DG (2000) Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion? Cancer 88:853–861
Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG (2000) Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 88:1663–1670
Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Nehra A, Malek RS, Zincke H, Bostwick DG (2000) Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer 88:1679–1686
Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, Kuzel TM, Papavero V, Tretiakova M, Nigro K, Koch MO, Eble JN (2004) Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101:957–962
Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, Lopez-Beltran A, Yang XJ, Koch MO, Zhang S, Pan CX, Baldridge LA (2005) Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol 166:1533–1539
Cheng L, Zhang S, Alexander R, Maclennan GT, Hodges KB, Harrison BT, Lopez-Beltran A, Montironi R (2011) Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation. Am J Surg Pathol 35:e34–e46
Cheng L, Lopez-Beltran A, Bostwick DG (Hrsg) (2012) Bladder Pathology. Wiley Blackwell, Hoboken, New Jersey
Choong NW, Quevedo JF, Kaur JS (2005) Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 103:1172–1178
Chrisofos M, Skolarikos A, Lazaris A, Bogris S, Deliveliotis Ch (2004) HPV 16/18-associated condyloma acuminatum of the urinary bladder: first international report and review of literature. Int J STD AIDS 15:836–838
Compérat E, Roupret M, Yaxley J, Reynolds J, Varinot J, Ouzaïd I, Cussenot O, Samaratunga H (2010) Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases. Pathology 42:650–654
Cox RM, Schneider AG, Sangoi AR, Clingan WJ, Gokden N, McKenney JK (2009) Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture. Am J Surg Pathol 33:1213–1219
Däuth TL, Conradie M, Chetty R (2003) Leiomyoma of the bladder in a patient with von Recklinghausen’s neurofibromatosis. J Clin Pathol 56:711–712
Dasupta T, Grabstald H (1965) Melanoma of the genitourinary tract. J Urol 193:607
Dietel M, Klöppel G (Hrsg) (2013) Pathologie. Mamma, Weibliches Genitale, Schwangerschaft und Kindererkrankungen. Springer, Berlin
Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon
El-Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussein MH (1981) The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer 48:2643–2648
el-Mawla NG, el-Bolkainy MN, Khaled HM (2001) Bladder cancer in Africa: update. Semin Oncol 28:174–178
Elsobky E, El-Baz M, Gomha M, Abol-Enein H, Shaaban AA (2002) Prognostic value of angiogenesis in schistosoma-associated squamous cell carcinoma of the urinary bladder. Urology 60:69–73
Epstein JI (2004) Biopsy Interpretation of the Bladder. Lippincott Williams & Wilkins, Philadelphia
Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29:252–260
Fritsche HM, Burger M, Denzinger S, Legal W, Goebell PJ, Hartmann A (2008) Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases. J Urol 180:1923–1927
Gilcrease MZ, Delgado R, Vuitch F, Albores-Saavedra J (1998) Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Hum Pathol 29:1451–1456
Goebell PJ, Groshen SG, Schmitz-Drager BJ (2010) p53 immunohistochemistry in bladder cancer – a new approach to an old question. Urol Oncol 28:377–88
Goertchen R, Seidenschnur A, Stosiek P (1994) Clinical pathology of inverted papillomas of the urinary bladder. A complex morphologic and catamnestic study (2). Pathologe 15:279–285
Goldstein AG (1967) Metastatic carcinoma to the bladder. J Urol 98:209–215
Golijanin D, Yossepowitch O, Beck SD, Sogani P, Dalbagni G (2003) Carcinoma in a bladder diverticulum: presentation and treatment outcome. J Urol 170:1761–1764
Gonul, II, Akyurek N, Dursun A, Kupeli B (2008) Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder. Pathol Res Pract 204:707–17
Grignon DJ, Ro JY, Ayala AG, Johnson DE (1991) Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol 95:13–20
Gulley ML, Amin MB, Nicholls JM, Banks PM, Ayala AG, Srigley JR, Eagan PA, Ro JY (1995) Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder. Hum Pathol 26:1207–1214
Guo CC, Gomez E, Tamboli P, Bondaruk JE, Kamat A, Bassett R, Dinney CP, Czerniak BA (2009) Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Hum Pathol 40:1448–1452
Gupta A, Wang HL, Policarpio-Nicolas ML, Tretiakova MS, Papavero V, Pins MR, Jiang Z, Humphrey PA, Cheng L, Yang XJ (2004) Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol 28:1224–1229
Gupta R, Mahajan A, Atri S, Gupta CL (2013) Recurrent painless hematuria secondary to malacoplakia of the urinary bladder: a case report and review of literature. Urol J 10:821–823
Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, Wolf JS Jr, Schellhammer PF (2007) Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178:2314–2330
Harik LR, Merino C, Coindre JM, Amin MB, Pedeutour F, Weiss SW (2006) Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol 30:787–794
Harnden P, Eardley I, Joyce AD, Southgate J (1996) Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 78:870–875
Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R (1999) Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 154:721–727
Hartmann A, Junker K, Dietmaier W, Schröder S, Lopez D, Hofstädter F, Blaszyk H (2006) Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma. Hum Pathol 37:117–120
Helpap B, Klöppel G (2002) Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge. Virchows Arch 440:241–248
Helpap B (2002) Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Cancer 95:1415–1420
Holck S, Jørgensen L (1983) Verrucous carcinoma of urinary bladder. Urology 22:435–437
Holmäng S, Borghede G, Johansson SL (1997) Primary signet ring cell carcinoma of the bladder: a report on 10 cases. Scand J Urol Nephrol 31:145–148
Holmäng S, Borghede G, Johansson SL (1998) Bladder carcinoma with lymphoepithelioma-like differentiation: a report of 9 cases. J Urol 159:779–782
Huang Q, Chu PG, Lau SK, Weiss LM (2004) Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma. Human Pathology 35:769–773
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Jiang XZ, Xu C, Zhang NZ, Xu ZS (2012) Influence of clinical characteristics and tumor size on symptoms of bladder leiomyoma: a pooled analysis of 61 cases. Chin Med J (Engl) 125:2436–2439
Jones EC, Clement PB, Young RH (1993) Inflammatory pseudotumor of the urinary bladder. A clinicopathological, immunohistochemical, ultrastructural, and flow cytometric study of 13 cases. Am J Surg Pathol 17:264–274
Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, Lin H, Pan CX, Tretiakova M, Baldridge LA, Cheng L (2005) Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 36:718–723
Jones TD, Zhang S, Lopez-Beltran A, Eble JN, Sung MT, MacLennan GT, Montironi R, Tan PH, Zheng S, Baldridge LA, Cheng L (2007) Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol 31:1861–1867
Kalafatis P, Kavantzas N, Pavlopoulos PM, Agapitos E, Politou M, Kranides A (2002) Malignant peripheral nerve sheath tumor of the urinary bladder in von Recklinghausen disease. Urol Int 69:156–159
Kassouf W, Spiess PE, Siefker-Radtke A, Swanson D, Grossman HB, Kamat AM, Munsell MF, Guo CC, Czerniak BA, Dinney CP (2007) Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience. Cancer 110:764–769
Kato H, Suzuki M, Mukai M, Aizawa S (1999) Clinicopathological study of pheochromocytoma of the urinary bladder: Immunohistochemical, flow cytometric and ultrastructural findings with review of the literature. Pathology International 49:1093–1099
Khaliq W, Uzoaru I, Konchanin RP, Sapiente RA, Egner JR (2010) Solitary extramedullary plasmacytoma of the bladder: a case report and literature. Oncology (Williston Park) 24:832–835
Knowles MA (2006) Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 27:361–373
Kohno T, Kitamura M, Akai H, Takaha M, Kawahara K, Oka T (2006) Plasmacytoid urothelial carcinoma of the bladder. Int J Urol 13:485–486
Kontani K, Okaneya T, Takezaki T (1999) Recurrent granular cell tumour of the bladder in a patient with von Recklinghausen’s disease. BJU Int 84:871–872
Kotliar SN, Wood CG, Schaeffer AJ, Oyasu R (1995) Transitional cell carcinoma exhibiting clear cell features. A differential diagnosis for clear cell adenocarcinoma of the urinary tract. Arch Pathol Lab Med 119:79–81
Kunze E, Theuring F, Krüger G (1994) Primary mesenchymal tumors of the urinary bladder. A histological and immunohistochemical study of 30 cases. Pathol Res Pract 190:311–332
Kunze E, Francksen B, Schulz H (2001) Expression of MUC5AC apomucin in transitional cell carcinomas of the urinary bladder and its possible role in the development of mucus-secreting adenocarcinomas. Virchows Arch 439:609–615
Lam KY, Ma L, Nicholls J (1992) Adenocarcinoma arising in a diverticulum of the urinary bladder. Pathology 24:40–42
Lamovec J, Zidar A, Trsinar B, Jancar J (1992) Sclerosing inflammatory pseudotumor of the urinary bladder in a child. Am J Surg Pathol 16:1233–1238
Lee TK, Miyamoto H, Osunkoya AO, Guo CC, Weiss SW, Epstein JI (2010) Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases. Am J Surg Pathol 34:502–509
Leroy X, Gonzalez S, Zini L, Aubert S (2007) Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases. Am J Surg Pathol 31:770–773
Leuschner I, Harms D, Mattke A, Koscielniak E, Treuner J (2001) Rhabdomyosarcoma of the urinary bladder and vagina: a clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study. Am J Surg Pathol 25:856–864
Lim M, Adsay NV, Grignon D, Osunkoya AO (2009) Urothelial carcinoma with villoglandular differentiation: a study of 14 cases. Mod Pathol 22:1280–1286
Lin O, Cardillo M, Dalbagni G, Linkov I, Hutchinson B, Reuter VE (2003) Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases. Mod Pathol 16:1289–1298
Lopez-Beltrán A, Luque RJ, Vicioso L, Anglada F, Requena MJ, Quintero A, Montironi R (2001) Virchows Arch. Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases 438:552–557
Lopez-Beltran A, Cheng L, Andersson L, Brausi M, de Matteis A, Montironi R, Sesterhenn I, van det Kwast KT, Mazerolles C (2002) Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation. Virchows Arch 440:3–11
Lopez-Beltran A, Luque RJ, Quintero A, Requena MJ, Montironi R (2003) Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch 442:381–387
Lopez-Beltran A, Cheng L (2006) Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol 37:1371–1388
Lopez-Beltran A, Requena MJ, Cheng L, Montironi R (2008) Pathological variants of invasive bladder cancer according to their suggested clinical significance. BJU Int 101:275–281
Lopez-Beltran A, Blanca A, Montironi R, Cheng L, Regueiro JC (2009) Pleomorphic giant cell carcinoma of the urinary bladder. Hum Pathol 40:1461–1466
Lopez-Beltran A, Requena MJ, Montironi R, Blanca A, Cheng L (2009) Plasmacytoid urothelial carcinoma of the bladder. Hum Pathol 40:1023–1028
Lopez-Beltran A, Amin MB, Oliveira PS, Montironi R, Algaba F, McKenney JK, de Torres I, Mazerolles C, Wang M, Cheng L (2010) Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Am J Surg Pathol 34:371–376
Lott S, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L (2007) Soft tissue tumors of the urinary bladder Part II: malignant neoplasms. Hum Pathol 38:963–977
Magi-Galluzzi C, Epstein JI (2004) Urothelial papilloma of the bladder: a review of 34 de novo cases. Am J Surg Pathol 28:1615–1620
Mallin K, David KA, Carroll PR, Milowsky Nanus MIDM (2007) Transitional celll carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993–2007). J Urol 185:1631–1636
Mason EF, Sadow PM, Wagner AJ, Remillard SP, Flood TA, Belanger EC, Hornick JL, Barletta JA (2013) Identification of Succinate Dehydrogenase-deficient Bladder Paragangliomas. Am J Surg Pathol 37:1612–1618
McKenney JK, Desai S, Cohen C, Amin MB (2001) Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol 25:1074–1078
Mikuz G (1993) Nicht-urotheliale Tumoren der ableitenden Harnwege. Verh Dtsch Ges Pathol 77:180–198
Miller JS, Epstein JI (2009) Noninvasive urothelial carcinoma of the bladder with glandular differentiation: report of 24 cases. Am J Surg Pathol 33:1241–1248
Mills SE, Bova GS, Wick MR, Young RH (1989) Leiomyosarcoma of the urinary bladder. A clinicopathologic and immunohistochemcal study of 15 cases. Am J Surg Pathol 13(6):480–489
Mogorovich A, Giannarini G, De Maria M, Manassero F, Selli C (2007) Granular cell tumour of the urinary bladder: a case report and review of the literature. Arch Ital Urol Androl 79:43–44
Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, Vaughn DJ, Griffin CA, Epstein JI (2006) Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol 30:1502–1512
Mostofi Sobin FKLH, Torloni H (Hrsg) (1973) International Histological Classification of Tumours. Histologic typing of urinary bladder tumors. WHO, Geneva
Murali R, Kneale K, Lalak N, Delprado W (2006) Carcinoid tumors of the urinary tract and prostate. Arch Pathol Lab Med 130:1693–1706
Murphy WM, Grignon DJ, Perlman EJ (2004) Tumors of the Kidney, Bladder and Related Urinary Structures. Atlas of Tumor Pathology, Fourth series, Fascicle 1. Armed Forces Institute of Pathology, Washington DC
Neves TR, Soares MJ, Monteiro PG, Lima MS, Monteiro HG (2011) Basaloid squamous cell carcinoma in the urinary bladder with small-cell carcinoma. J Clin Oncol 29:e440–e442
Nigwekar PAMB (2008) The many faces of urothelial carcinoma: an update with an emphasis on recently described variants. Adv Anat Pathol 15:218–233
Nigwekar P, Tamboli P, Amin MB, Osunkoya AO, Ben-Dor D, Amin MB (2009) Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases. Am J Surg Pathol 33:417–424
Nochomovitz LE, Orenstein JM (1985) Inflammatory pseudotumor of the urinary bladder – possible relationship to nodular fasciitis. Two case reports, cytologic observations, and ultrastructural observations. Am J Surg Pathol 9:366–373
Obermann EC, Junker K, Stoehr R, Dietmaier W, Zaak D, Schubert J, Hofstaedter F, Knuechel R, Hartmann A (2003) Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. J Pathol 199:50–57
Oguzkan S, Terzi YK, Güler E, Derbent M, Agras PI, Saatci U, Ayter S (2006) Two neurofibromatosis type 1 cases associated with rhabdomyosarcoma of bladder, one with a large deletion in the NF1 gene. Cancer Genet Cytogenet 164:159–163
Ohsawa M, Aozasa K, Horiuchi K, Kanamaru A (1993) Malignant lymphoma of bladder. Report of three cases and review of the literature. Cancer 72:1969–1974
Oliva E, Amin MB, Jimenez R, Young RH (2002) Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol 26:190–197
Oliva E, Pinheiro NF, Heney NM, Kaufman DS, Shipley WU, Gurski C, Spicer B, Paner GP, Gown AM, Amin MB (2013) Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases. Hum Pathol 2013;44(5):860–866
Ooi A, Nakanishi I, Sakamoto N, Tsukada Y, Takahashi Y, Minamoto T, Mai M (1990) Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation? Cancer 65:1741–1747
Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Smeets AW, Pauwels RP (2000) MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors. Cancer 88:2598–2605
Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F (2002) Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol 55:900–905
Pacella M, Gallo F, Gastaldi C, Ambruosi C, Carmignani G (2006) Primary malignant melanoma of the bladder. Int J Urol 13:635–637
Pan CC, Chang YH, Chen KK, Yu HJ, Sun CH, Ho DM (2004) Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am J Clin Pathol 133:788–795
Paner GP, McKenney JK, Epstein JI, Amin MB (2008) Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am J Surg Pathol 32:1022–1028
Park SB, Park YS, Kim JK, Kim MH, Oh YT, Kim KA, Cho KS (2011) Solitary fibrous tumor of the genitourinary tract. AJR Am J Roentgenol 196:W132–137
Park S, Ro JY, Lee DH, Choi SY, Koo H (2013) Immunoglobulin G4-associated inflammatory pseudotumor of urinary bladder: a case report. Ann Diagn Pathol 17:540–543
Parwani AV, Herawi M, Volmar K, Tsay SH, Epstein JI (2006) Urothelial carcinoma with rhabdoid features: report of 6 cases. Hum Pathol 37:168–172
Pham A, Steinberg A, Kwok B, Lopez A, Lim S, Lill M (2011) Precursor T-Cell acute lymphoblastic leukemia/lymphoma with rare presentation in the urinary bladder. Hematol Rep 3:e18
Pich A, Chiusa L, Formiconi A, Galliano D, Bortolin P, Navone R (2001) Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. Am J Surg Pathol 25:1528–1533
Quintero A, Alvarez-Kindelan J, Luque RJ, Gonzalez-Campora R, Requena MJ, Montironi R, Lopez-Beltran A (2006) Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder. J Clin Pathol 59:83–88
Ro JY, Shen SS, Lee HI, Hong EK, Lee YH, Cho NH, Jung SJ, Choi YJ, Ayala AG (2008) Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases. Am J Surg Pathol 32:752–757
Roth JA (1980) Reactive pseudosarcomatous response in urinary bladder. Urolog 635(16):637
Rubenwolf PC, Eder F, Ebert A-K, Hofstaedter F, Woodhouse CR, Roesch WH (2013) Persistent Histological Changes in the Exstrophic Bladder After Primary Closure – A Cause for Concern? J Urol 189:671–677
Sahin AA, Myhre M, Ro JY, Sneige N, Dekmezian RH, Ayala AG (1991) Plasmacytoid transitional cell carcinoma. Report of a case with initial presentation mimicking multiple myeloma. Acta Cytol 35:277–280
Samaratunga H, Makarov DV, Epstein JI (2002) Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 60:315–319
Samaratunga H, Khoo K (2004) Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 45:55–64
Samaratunga H, Delahunt B (2012) Recently described and unusual variants of urothelial carcinoma of the urinary bladder. Pathology 44:407–418
Sari A, Bal K, Tunakan M, Ozturk C (2011) A case of a sporadic malignant peripheral nerve sheath tumor of the urinary bladder with concomitant in situ urothelial carcinoma treated by transuretheral resection. Indian J Pathol Microbiol 54:147–149
Schned AR, Andrew AS, Marsit CJ, Kelsey KT, Zens MS, Karagas MR (2008) Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scand J Urol Nephrol 42:237–242
Shattock SG (1910) Rhabdomyoma of the Urinary Bladder. Proc R Soc Med 3(Pathol Sect):31–41
Scheithauer BW, Santi M, Richter ER, Belman B, Rushing EJ (2008) Diffuse ganglioneuromatosis and plexiform neurofibroma of the urinary bladder: report of a pediatric example and literature review. Hum Pathol 39:1708–1712
Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE (1984) Malignant urachal lesions. J Urol 131:1–8
Shokeir AA (2004) Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int 93:216–220
Simoneau M, LaRue H, Aboulkassim TO (2000) Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest. Oncogene 19:6317–6323
Skeldon SC, Semotiuk K, Aronson M, Holter S, Gallinger S, Pollett A, Kuk C, van Rhijn B, Bostrom P, Cohen Z, Fleshner NE, Jewett MA, Hanna S, Shariat SF, Van Der Kwast TH, Evans A, Catto J, Bapat B, Zlotta AR (2013) Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Eur Urol 63:379–385
Soriano P, Navarro S, Gil M, Llombart-Bosch A (2004) Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases. Virchows Arch 445:292–297
Stein JP, Skinner EC, Boyd SD, Skinner DG (1993) Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener’s granulomatosis: a report of 2 cases. J Urol 149:588–589
Stoehr R, Zietz S, Burger M, Filbeck T, Denzinger S, Obermann EC, Hammerschmied C, Wieland WF, Knuechel R, Hartmann A (2005) Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. Eur Urol 47(1):58–63
Sung MT, Wang M, MacLennan GT, Eble JN, Tan PH, Lopez-Beltran A, Montironi R, Harris JJ, Kuhar M, Cheng L (2007) Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol 211:420–430
Sung MT, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R, Wang M, Tan PH, Cheng L (2008) Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res 14:1947–1955
Sung MT, Zhang S, Lopez-Beltran A, Montironi R, Wang M, Davidson DD, Koch MO, Cain MP, Rink RC, Cheng L (2009) Urothelial carcinoma following augmentation cystoplasty: an aggressive variant with distinct clinicopathological characteristics and molecular genetic alterations. Histopathology 55:161–173
Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466–465 (discussion 75–77)
Tavora F, Montgomery E, Epstein JI (2008) A series of vascular tumors and tumorlike lesions of the bladder. Am J Surg Pathol 32:1213–1219
Taylor DC, Bhagavan BS, Larsen MP, Cox JA, Epstein JI (1996) Papillary urothelial hyperplasia. A precursor to papillary neoplasms. Am J Surg Pathol 20:1481–1488
Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE (2009) Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol 40:108–116
Torenbeek R, Blomjous CE, de Bruin PC, Newling DW, Meijer CJ (1994) Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings. Am J Surg Pathol 18:241–249
Torenbeek R, Koot RA, Blomjous CE, De Bruin PC, Newling DW, Meijer CJ (1996) Primary signet-ring cell carcinoma of the urinary bladder. Histopathology 28:33–40
Vakar-López FAJ (2000) Basaloid squamous cell carcinoma occurring in the urinary bladder. Arch Pathol Lab Med 124:455–459
van der Post RS, Kiemeney LA, Ligtenberg MJ, Witjes JA, de Hulsbergen-van Kaa CA, Bodmer D, Schaap L, Kets CM, van Krieken JH, Hoogerbrugge N (2010) Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet 47:464–470
van Oers JM, Adam C, Denzinger S, Stoehr R, Bertz S, Zaak D, Stief C, Hofstaedter F, Zwarthoff EC, van der Kwast TH, Knuechel R, Hartmann A (2006) Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder. Int J Cancer 119:1212–1215
van Rhijn BW, Montironi R, Zwarthoff EC (2002) Frequent FGFR3 mutations in urothelial papilloma. J Pathol 198:245–251
van Rhijn, BW, Vis AN, van der Kwast TH, Kirkels WJ, Radvanyi F, Ooms EC, Chopin DK, Boevé ER, Jöbsis AC, Zwarthoff EC (2003) Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior topathologic grade for the prediction of clinical outcome. J Clin Oncol 21:1912–1921
Wallmeroth A, Wagner U, Moch H, Gasser TC, Sauter G, Mihatsch MJ (1999) Patterns of metastasis in muscle invasive bladder cancer (pT2-4): An autopsy study on 367 patients. Urol Int 62:69–75
Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, Yang XJ (2001) Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol 25:1380–1387
Wang W, Montgomery E, Epstein JI (2008) Benign nerve sheath tumors on urinary bladder biopsy. Am J Surg Pathol 32:907–912
Warne RR, Ong JS, Snowball B, Vivian JB (2011) Primary angiosarcoma of the bladder in a young female. BMJ Case Rep 2011 Apr 1;2011. pii: brc1120103484. doi: 10.1136/bcr.11.2010.3484
Wasco MJ, Daignault S, Zhang Y, Kunju LP, Kinnaman M, Braun T, Lee CT, Shah RB (2007) Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 70:69–74
Wasco MJ, Daignault S, Bradley D, Shah RB (2010) Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases. Hum Pathol 41:163–171
Wheeler JD, Hill WT (1954) Adenocarcinoma involving the urinary bladder. Cancer 7:119–135
Williamson SR, Lopez-Beltran A, Montironi R, Cheng L (2011) Glandular lesions of the urinary bladder:clinical significance and differential diagnosis. Histopathology 58:811–834
Williamson SR, Zhang S, Yao JL, Huang J, Lopez-Beltran A, Shen S, Osunkoya AO, MacLennan GT, Montironi R, Cheng L (2011) ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol 24:1120–1127
Williamson SR, Bunde PJ, Montironi R, Lopez-Beltran A, Zhang S, Wang M, Maclennan GT, Cheng L (2013) Malignant Perivascular Epithelioid Cell Neoplasm (PEComa) of the Urinary Bladder With TFE3 Gene Rearrangement: Clinicopathologic, Immunohistochemical, and Molecular Features. Am J Surg Pathol 37:1619–1626
Wittekind C, Meyer HJ (2010) UICC. TNM-Klassifikation maligner Tumoren, 7. Aufl. Wiley-VCH, Weinheim
Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP, Lin DW (2007) Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J Urol 178:2302–2306 (discussion 2307)
Xiao GQ, Burstein DE, Miller LK, Unger (2006) Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma. Arch Pathol Lab Med 130:805–810
Yin H, Leong AS (2004) Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Am J Clin Pathol 121:679–687
Yin H, He Q, Li T, Leong AS (2006) Cytokeratin 20 and Ki-67 to distinguish carcinoma in situ from flat non-neoplastic urothelium. Appl Immunohistochem Mol Morphol 14:260–265
Yin L, Bu H, Chen M, Yu J, Zhuang H, Chen J, Zhang H (2012) Perivascular epithelioid cell neoplasm of the urinary bladder in an adolescent: a case report and review of the literature. Diagn Pathol 7:183
Young RH, Eble JN (1991) Unusual forms of carcinoma of the urinary bladder. Hum Pathol 22:948–965
Young RH, Zukerberg LR (1991) Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases. Am J Clin Pathol 96:635–639
Young RH, Oliva E (1996) Transitional cell carcinomas of the urinary bladder that may be underdiagnosed. A report of four invasive cases exemplifying the homology between neoplastic and non-neoplastic transitional cell lesions. Am J Surg Pathol 20:1448–1454
Young RH (2009) Tumor-like lesions of the urinary bladder. Mod Pathol 22(2):37–52
Zhou M, Epstein JI, Young RH (2004) Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens. Am J Surg Pathol 28:94–100
Zieger K, Jensen KM (2011) Long-term risk of progression of carcinoma in situ of the bladder and impact of bacille Calmette-Guerin immunotherapy on the outcome. Scand J Urol Nephrol 45:411–418
Zukerberg LR, Armin AR, Pisharodi L, Young RH (1990) Transitional cell carcinoma of the urinary bladder with osteoclast-type giant cells: a report of two cases and review of the literature. Histopathology 17:407–411
Zukerberg LR, Harris NL, Young RH (1991) Carcinomas of the urinary bladder simulating malignant lymphoma. A report of five cases. Am J Surg Pathol 15:569–576
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Agaimy, A., Bertz, S., Hartmann, A., Minner, S., Sauter, G. (2016). Tumoren und tumorartige Veränderungen der Harnblase. In: Amann, K., Kain, R., Klöppel, G. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04566-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-04566-0_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-04565-3
Online ISBN: 978-3-642-04566-0
eBook Packages: Medicine (German Language)